Advertisement

The role of PAPP-A in the IGF system: location, location, location

  • Claus Oxvig
REVIEW

Abstract

Although discovered as a placental protein present abundantly in the circulation of pregnant women, pregnancy-associated plasma protein-A (PAPP-A) is widely expressed in multiple tissues. PAPP-A is a highly specific metalloproteinase binding tightly to glycosaminoglycans present on the surface of cells. By cleaving a subset of insulin-like growth factor binding proteins (IGFBPs), PAPP-A thus functions within tissues as a growth-promoting enzyme, releasing bioactive IGF in close proximity to the IGF receptor. IGFBP-4 is believed to be the principal PAPP-A substrate, and the focus in this review is on PAPP-A enzymatic activity and its role in the PAPP-A-IGFBP-4-IGF axis, which is subject to regulation at several different levels. These include e.g., transcriptional control, competing reactions potentially sequestering IGF from IGFBP-4 and hence antagonizing PAPP-A-mediated IGF activation, and proteolytic inhibition of PAPP-A. The latter may involve the protein stanniocalcin-2 (STC2), recently found to potently inhibit PAPP-A activity by forming a covalent complex with PAPP-A. PAPP-A or complex-bound variants may escape from pathological tissues into the circulation. It is emphasized that the potential use of PAPP-A as a diagnostic or predictive biomarker in nonpregnant individuals requires precise knowledge of analyte identity and assay specificity in addition to an appropriate material for standardization. Finally, PAPP-A may serve as a therapeutic target to indirectly inhibit IGF signaling in tissues where this is driven by increased PAPP-A activity. By taking advantage of the intricate interaction between PAPP-A and IGFBP-4, highly specific and selective inhibition of PAPP-A is possible.

Keywords

Insulin-like growth factor (IGF) Insulin-like growth factor binding protein (IGFBP) Pappalysin Pregnancy-associated plasma protein-A (PAPP-A) Proform of eosinophil major basic protein (proMBP) Stanniocalcin (STC) 

References

  1. Bale LK, Chakraborty S, Conover CA (2014) Inducible reduction in pregnancy-associated plasma protein-A gene expression inhibits established atherosclerotic plaque progression in mice. Endocrinology 155:1184–1187PubMedCentralPubMedGoogle Scholar
  2. Bale LK, Conover CA (2005) Disruption of insulin-like growth factor-II imprinting during embryonic development rescues the dwarf phenotype of mice null for pregnancy-associated plasma protein-A. J Endocrinol 186:325–331PubMedGoogle Scholar
  3. Baxter RC (2014) IGF binding proteins in cancer: mechanistic and clinical insights. Nat Rev Cancer 14:329–341PubMedGoogle Scholar
  4. Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR Jr, Virmani R, Oxvig C, Schwartz RS (2001a) Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 345:1022–1029PubMedGoogle Scholar
  5. Bayes-Genis A, Schwartz RS, Lewis DA, Overgaard MT, Christiansen M, Oxvig C, Ashai K, Holmes DR Jr, Conover CA (2001b) Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler Thromb Vasc Biol 21:335–341PubMedGoogle Scholar
  6. Bersinger NA, Zakher A, Huber U, Pescia G, Schneider H (1995) A sensitive enzyme immunoassay for pregnancy-associated plasma protein A (PAPP-A): a possible first trimester method of screening for Down syndrome and other trisomies. Arch Gynecol Obstet 256:185–192PubMedGoogle Scholar
  7. Boldt HB, Conover CA (2011) Overexpression of pregnancy-associated plasma protein-A in ovarian cancer cells promotes tumor growth in vivo. Endocrinology 152:1470–1478PubMedGoogle Scholar
  8. Boldt HB, Glerup S, Overgaard MT, Sottrup-Jensen L, Oxvig C (2006) Definition, expression, and characterization of a protein domain in the N-terminus of pregnancy-associated plasma protein-A distantly related to the family of laminin G-like modules. Protein Expr Purif 48:261–273PubMedGoogle Scholar
  9. Boldt HB, Kjaer-Sorensen K, Overgaard MT, Weyer K, Poulsen CB, Sottrup-Jensen L, Conover CA, Giudice LC, Oxvig C (2004) The Lin12-notch repeats of pregnancy-associated plasma protein-A bind calcium and determine its proteolytic specificity. J Biol Chem 279:38525–38531PubMedGoogle Scholar
  10. Boldt HB, Overgaard MT, Laursen LS, Weyer K, Sottrup-Jensen L, Oxvig C (2001) Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin. Biochem J 358:359–367PubMedCentralPubMedGoogle Scholar
  11. Bonno M, Oxvig C, Kephart GM, Wagner JM, Kristensen T, Sottrup-Jensen L, Gleich GJ (1994) Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest 71:560–566PubMedGoogle Scholar
  12. Bueler MR, Bersinger NA (1989) Antiserum to pregnancy-associated plasma protein A (PAPP-A) recognizes human haptoglobin. Br J Obstet Gynaecol 96:867–869PubMedGoogle Scholar
  13. Bulut I, Coskun A, Ciftci A, Cetinkaya E, Altiay G, Caglar T, Gulcan E (2009) Relationship between pregnancy-associated plasma protein-A and lung cancer. Am J Med Sci 337:241–244PubMedGoogle Scholar
  14. Bunn RC, Fowlkes JL (2003) Insulin-like growth factor binding protein proteolysis. Trends Endocrinol Metab 14:176–181PubMedGoogle Scholar
  15. Callahan G, Denison SR, Phillips LA, Shridhar V, Smith DI (2003) Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene 22:590–601PubMedGoogle Scholar
  16. Cerda-Costa N, Gomis-Ruth FX (2014) Architecture and function of metallopeptidase catalytic domains. Protein Sci 23:123–144PubMedCentralPubMedGoogle Scholar
  17. Chander H, Halpern M, Resnick-Silverman L, Manfredi JJ, Germain D (2011) Skp2B overexpression alters a prohibitin-p53 axis and the transcription of PAPP-A, the protease of insulin-like growth factor binding protein 4. PLoS One 6:e22456PubMedCentralPubMedGoogle Scholar
  18. Chang AC, Hook J, Lemckert FA, McDonald MM, Nguyen MA, Hardeman EC, Little DG, Gunning PW, Reddel RR (2008) The murine stanniocalcin 2 gene is a negative regulator of postnatal growth. Endocrinology 149:2403–2410PubMedGoogle Scholar
  19. Chang AC, Jellinek DA, Reddel RR (2003) Mammalian stanniocalcins and cancer. Endocr Relat Cancer 10:359–373PubMedGoogle Scholar
  20. Chen BK, Leiferman KM, Pittelkow MR, Overgaard MT, Oxvig C, Conover CA (2003) Localization and regulation of pregnancy-associated plasma protein a expression in healing human skin. J Clin Endocrinol Metab 88:4465–4471PubMedGoogle Scholar
  21. Conover CA (2012) Key questions and answers about pregnancy-associated plasma protein-A. Trends Endocrinol Metab 23:242–249PubMedCentralPubMedGoogle Scholar
  22. Conover CA, Bale LK (2007) Loss of pregnancy-associated plasma protein A extends lifespan in mice. Aging Cell 6:727–729PubMedGoogle Scholar
  23. Conover CA, Bale LK, Harrington SC, Resch ZT, Overgaard MT, Oxvig C (2006) Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol. Am J Physiol Cell Physiol 290:C183–C188PubMedGoogle Scholar
  24. Conover CA, Bale LK, Mader JR, Mason MA, Keenan KP, Marler RJ (2010) Longevity and age-related pathology of mice deficient in pregnancy-associated plasma protein-A. J Gerontol A Biol Sci Med Sci 65:590–599PubMedGoogle Scholar
  25. Conover CA, Bale LK, Overgaard MT, Johnstone EW, Laursen UH, Fuchtbauer EM, Oxvig C, van Deursen J (2004a) Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 131:1187–1194PubMedGoogle Scholar
  26. Conover CA, Chen BK, Resch ZT (2004b) Regulation of pregnancy-associated plasma protein-A expression in cultured human osteoblasts. Bone 34:297–302PubMedGoogle Scholar
  27. Conover CA, Faessen GF, Ilg KE, Chandrasekher YA, Christiansen M, Overgaard MT, Oxvig C, Giudice LC (2001) Pregnancy-associated plasma protein-a is the insulin-like growth factor binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of dominant follicle selection and the corpus luteum. Endocrinology 142:2155PubMedGoogle Scholar
  28. Conover CA, Harrington SC, Bale LK (2008) Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells. Growth Horm IGF Res 18:213–220PubMedCentralPubMedGoogle Scholar
  29. Conover CA, Harstad SL, Tchkonia T, Kirkland JL (2013) Preferential impact of pregnancy-associated plasma protein-A deficiency on visceral fat in mice on high-fat diet. Am J Physiol Endocrinol Metab 305:E1145–E1153PubMedCentralPubMedGoogle Scholar
  30. Conover CA, Oxvig C, Overgaard MT, Christiansen M, Giudice LC (1999) Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A. J Clin Endocrinol Metab 84:4742–4745PubMedGoogle Scholar
  31. Consuegra-Sanchez L, Fredericks S, Kaski JC (2009) Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk. Atherosclerosis 203:346–352PubMedGoogle Scholar
  32. Dalgin GS, Holloway DT, Liou LS, DeLisi C (2007) Identification and characterization of renal cell carcinoma gene markers. Cancer Inform 3:65–92PubMedCentralPubMedGoogle Scholar
  33. DeChiara TM, Efstratiadis A, Robertson EJ (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78–80PubMedGoogle Scholar
  34. Fenwick JC, So YP (1974) A perfusion study of the effect of stanniectomy on the net influx of calcium 45 across an isolated eel gill (1). J Exp Zool 188:125–131PubMedGoogle Scholar
  35. Firth SM, Baxter RC (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824–854PubMedGoogle Scholar
  36. Forbes BE, McCarthy P, Norton RS (2012) Insulin-like growth factor binding proteins: a structural perspective. Front Endocrinol (Lausanne) 3:38Google Scholar
  37. Gagliardi AD, Kuo EY, Raulic S, Wagner GF, DiMattia GE (2005) Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs. Am J Physiol Endocrinol Metab 288:E92–E105PubMedGoogle Scholar
  38. Gaidamauskas E, Gyrup C, Boldt HB, Schack VR, Overgaard MT, Laursen LS, Oxvig C (2013) IGF dependent modulation of IGF binding protein (IGFBP) proteolysis by pregnancy-associated plasma protein-A (PAPP-A): multiple PAPP-A-IGFBP interaction sites. Biochim Biophys Acta 1830:2701–2709PubMedGoogle Scholar
  39. Giudice LC, Conover CA, Bale L, Faessen GH, Ilg K, Sun I, Imani B, Suen LF, Irwin JC, Christiansen M, Overgaard MT, Oxvig C (2002) Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. J Clin Endocrinol Metab 87:2359–2366PubMedGoogle Scholar
  40. Glerup S, Boldt HB, Overgaard MT, Sottrup-Jensen L, Giudice LC, Oxvig C (2005) Proteinase inhibition by proform of eosinophil major basic protein (pro-MBP) is a multistep process of intra- and intermolecular disulfide rearrangements. J Biol Chem 280:9823–9832PubMedGoogle Scholar
  41. Glerup S, Kloverpris S, Laursen LS, Dagnaes-Hansen F, Thiel S, Conover CA, Oxvig C (2007) Cell surface detachment of pregnancy-associated plasma protein-A requires the formation of intermolecular proteinase-inhibitor disulfide bonds and glycosaminoglycan covalently bound to the inhibitor. J Biol Chem 282:1769–1778PubMedGoogle Scholar
  42. Guo F, Li Y, Wang J, Li Y, Li Y, Li G (2013) Stanniocalcin1 (STC1) inhibits cell proliferation and invasion of cervical cancer cells. PLoS One 8:e53989PubMedCentralPubMedGoogle Scholar
  43. Gyrup C, Christiansen M, Oxvig C (2007) Quantification of proteolytically active pregnancy-associated plasma protein-A with an assay based on quenched fluorescence. Clin Chem 53:947–954PubMedGoogle Scholar
  44. Gyrup C, Oxvig C (2007) Quantitative analysis of insulin-like growth factor-modulated proteolysis of insulin-like growth factor binding protein −4 and −5 by pregnancy-associated plasma protein-A. Biochemistry 46:1972–1980PubMedGoogle Scholar
  45. Harrington SC, Simari RD, Conover CA (2007) Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Circ Res 100:1696–1702PubMedGoogle Scholar
  46. Heidegger I, Pircher A, Klocker H, Massoner P (2011) Targeting the insulin-like growth factor network in cancer therapy. Cancer Biol Ther 11:701–707PubMedGoogle Scholar
  47. Huang J, Tabata S, Kakiuchi S, Van The T, Goto H, Hanibuchi M, Nishioka Y (2013) Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic target. Oncotarget 4:1172–1184PubMedCentralPubMedGoogle Scholar
  48. Jepsen MR, Kloverpris S, Mikkelsen JH, Pedersen JH, Fuchtbauer EM, Laursen LS, Oxvig C (2014) Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis. J Biol Chem. doi: 10.1074/jbc.M114.611665 PubMedGoogle Scholar
  49. Joensuu K, Heikkila P, Andersson LC (2008) Tumor dormancy: elevated expression of stanniocalcins in late relapsing breast cancer. Cancer Lett 265:76–83PubMedGoogle Scholar
  50. Junnila RK, List EO, Berryman DE, Murrey JW, Kopchick JJ (2013) The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol 9:366–376PubMedCentralPubMedGoogle Scholar
  51. Kalli KR, Chen BK, Bale LK, Gernand E, Overgaard MT, Oxvig C, Cliby WA, Conover CA (2004) Pregnancy-associated plasma protein-A (PAPP-A) expression and insulin-like growth factor binding protein-4 protease activity in normal and malignant ovarian surface epithelial cells. Int J Cancer 110:633–640PubMedGoogle Scholar
  52. Kalousova M, Zima T, Krane V, Marz W, Wanner C, Tesar V, Drechsler C, German D, Dialysis Study I (2014) Pregnancy-associated plasma protein A associates with cardiovascular events in diabetic hemodialysis patients. Atherosclerosis 236:263–269PubMedGoogle Scholar
  53. Kirkegaard I, Uldbjerg N, Oxvig C (2010) Biology of pregnancy-associated plasma protein-A in relation to prenatal diagnostics: an overview. Acta Obstet Gynecol Scand 89:1118–1125PubMedGoogle Scholar
  54. Kjaer-Sorensen K, Engholm DH, Jepsen MR, Morch MG, Weyer K, Hefting LL, Skov LL, Laursen LS, Oxvig C (2014) Pregnancy-associated plasma protein-A2 modulates development of cranial cartilage and angiogenesis in zebrafish embryos. J Cell SciGoogle Scholar
  55. Kjaer-Sorensen K, Engholm DH, Kamei H, Morch MG, Kristensen AO, Zhou J, Conover CA, Duan C, Oxvig C (2013) Pregnancy-associated plasma protein A (PAPP-A) modulates the early developmental rate in zebrafish independently of its proteolytic activity. J Biol Chem 288:9982–9992PubMedCentralPubMedGoogle Scholar
  56. Kristensen T, Oxvig C, Sand O, Moller NP, Sottrup-Jensen L (1994) Amino acid sequence of human pregnancy-associated plasma protein-A derived from cloned cDNA. Biochemistry 33:1592–1598PubMedGoogle Scholar
  57. Kuhajda FP, Eggleston JC (1985) Pregnancy-associated plasma protein A. A clinically significant predictor of early recurrence in stage I breast carcinoma is independent of estrogen receptor status. Am J Pathol 121:342–348PubMedCentralPubMedGoogle Scholar
  58. Kuhajda FP, Katumuluwa AI, Pasternack GR (1989) Expression of haptoglobin-related protein and its potential role as a tumor antigen. Proc Natl Acad Sci U S A 86:1188–1192PubMedCentralPubMedGoogle Scholar
  59. Laursen LS, Kjaer-Sorensen K, Andersen MH, Oxvig C (2007) Regulation of insulin-like growth factor (IGF) bioactivity by sequential proteolytic cleavage of IGF binding protein −4 and −5. Mol Endocrinol 21:1246–1257PubMedGoogle Scholar
  60. Laursen LS, Overgaard MT, Nielsen CG, Boldt HB, Hopmann KH, Conover CA, Sottrup-Jensen L, Giudice LC, Oxvig C (2002a) Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis. Biochem J 367:31–40PubMedCentralPubMedGoogle Scholar
  61. Laursen LS, Overgaard MT, Soe R, Boldt HB, Sottrup-Jensen L, Giudice LC, Conover CA, Oxvig C (2001) Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett 504:36–40PubMedGoogle Scholar
  62. Laursen LS, Overgaard MT, Weyer K, Boldt HB, Ebbesen P, Christiansen M, Sottrup-Jensen L, Giudice LC, Oxvig C (2002b) Cell surface targeting of pregnancy-associated plasma protein A proteolytic activity. Reversible adhesion is mediated by two neighboring short consensus repeats. J Biol Chem 277:47225–47234PubMedGoogle Scholar
  63. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR 3rd, Conover CA (1999) The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A 96:3149–3153PubMedCentralPubMedGoogle Scholar
  64. Li Y, Zhou C, Zhou X, Song L, Hui R (2013) PAPP-A in cardiac and non-cardiac conditions. Clin Chim Acta 417:67–72PubMedGoogle Scholar
  65. Lin TM, Halbert SP, Spellacy WN (1974) Measurement of pregnancy-associated plasma proteins during human gestation. J Clin Invest 54:576–582PubMedCentralPubMedGoogle Scholar
  66. Loddo M, Andryszkiewicz J, Rodriguez-Acebes S, Stoeber K, Jones A, Dafou D, Apostolidou S, Wollenschlaeger A, Widschwendter M, Sainsbury R, Tudzarova S, Williams GH (2014) Pregnancy-associated plasma protein A regulates mitosis and is epigenetically silenced in breast cancer. J Pathol 233:344–356PubMedGoogle Scholar
  67. Mader JR, Resch ZT, McLean GR, Mikkelsen JH, Oxvig C, Marler RJ, Conover CA (2013) Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy. J Endocrinol 219:51–58PubMedCentralPubMedGoogle Scholar
  68. Mansfield AS, Visscher DW, Hart SN, Wang C, Goetz MP, Oxvig C, Conover CA (2014) Pregnancy-associated plasma protein-A expression in human breast cancer. Growth Horm IGF Res 24:264–267PubMedGoogle Scholar
  69. Mikkelsen JH, Gyrup C, Kristensen P, Overgaard MT, Poulsen CB, Laursen LS, Oxvig C (2008) Inhibition of the proteolytic activity of pregnancy-associated plasma protein-A by targeting substrate exosite binding. J Biol Chem 283:16772–16780PubMedGoogle Scholar
  70. Mikkelsen JH, Resch ZT, Kalra B, Savjani G, Kumar A, Conover CA, Oxvig C (2014) Indirect targeting of IGF receptor signaling in vivo by substrate-selective inhibition of PAPP-A proteolytic activity. Oncotarget 5:1014–1025PubMedCentralPubMedGoogle Scholar
  71. Miyakoshi N, Qin X, Kasukawa Y, Richman C, Srivastava AK, Baylink DJ, Mohan S (2001) Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism. Endocrinology 142:2641–2648PubMedGoogle Scholar
  72. Monget P, Mazerbourg S, Delpuech T, Maurel MC, Maniere S, Zapf J, Lalmanach G, Oxvig C, Overgaard MT (2003) Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation. Biol Reprod 68:77–86PubMedGoogle Scholar
  73. Nagarajan N, Bertrand D, Hillmer AM, Zang ZJ, Yao F, Jacques PE, Teo AS, Cutcutache I, Zhang Z, Lee WH, Sia YY, Gao S, Ariyaratne PN, Ho A, Woo XY, Veeravali L, Ong CK, Deng N, Desai KV, Khor CC, Hibberd ML, Shahab A, Rao J, Wu M, Teh M, Zhu F, Chin SY, Pang B, So JB, Bourque G, Soong R, Sung WK, Tean Teh B, Rozen S, Ruan X, Yeoh KG, Tan PB, Ruan Y (2012) Whole-genome reconstruction and mutational signatures in gastric cancer. Genome Biol 13:R115PubMedCentralPubMedGoogle Scholar
  74. Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69:562–573PubMedGoogle Scholar
  75. Ning Y, Schuller AG, Bradshaw S, Rotwein P, Ludwig T, Frystyk J, Pintar JE (2006) Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein −3, −4, and −5. Mol Endocrinol 20:2173–2186PubMedGoogle Scholar
  76. Ning Y, Schuller AG, Conover CA, Pintar JE (2008) Insulin-like growth factor (IGF) binding protein-4 is both a positive and negative regulator of IGF activity in vivo. Mol Endocrinol 22:1213–1225PubMedCentralPubMedGoogle Scholar
  77. Nyegaard M, Overgaard MT, Su YQ, Hamilton AE, Kwintkiewicz J, Hsieh M, Nayak NR, Conti M, Conover CA, Giudice LC (2010) Lack of functional pregnancy-associated plasma protein-A (PAPPA) compromises mouse ovarian steroidogenesis and female fertility. Biol Reprod 82:1129–1138PubMedCentralPubMedGoogle Scholar
  78. Ortiz CO, Chen BK, Bale LK, Overgaard MT, Oxvig C, Conover CA (2003) Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts. J Bone Miner Res 18:1066–1072PubMedGoogle Scholar
  79. Overgaard MT, Boldt HB, Laursen LS, Sottrup-Jensen L, Conover CA, Oxvig C (2001) Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase. J Biol Chem 276:21849–21853PubMedGoogle Scholar
  80. Overgaard MT, Glerup S, Boldt HB, Rodacker V, Olsen IM, Christiansen M, Sottrup-Jensen L, Giudice LC, Oxvig C (2004) Inhibition of proteolysis by the proform of eosinophil major basic protein (proMBP) requires covalent binding to its target proteinase. FEBS Lett 560:147–152PubMedGoogle Scholar
  81. Overgaard MT, Haaning J, Boldt HB, Olsen IM, Laursen LS, Christiansen M, Gleich GJ, Sottrup-Jensen L, Conover CA, Oxvig C (2000) Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 275:31128–31133PubMedGoogle Scholar
  82. Overgaard MT, Oxvig C, Christiansen M, Lawrence JB, Conover CA, Gleich GJ, Sottrup-Jensen L, Haaning J (1999) Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: expression in human reproductive and nonreproductive tissues. Biol Reprod 61:1083–1089PubMedGoogle Scholar
  83. Overgaard MT, Sorensen ES, Stachowiak D, Boldt HB, Kristensen L, Sottrup-Jensen L, Oxvig C (2003) Complex of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein. Disulfide structure and carbohydrate attachment. J Biol Chem 278:2106–2117PubMedGoogle Scholar
  84. Oxvig C, Haaning J, Hojrup P, Sottrup-Jensen L (1994a) Location and nature of carbohydrate groups in proform of human major basic protein isolated from pregnancy serum. Biochem Mol Biol Int 33:329–336PubMedGoogle Scholar
  85. Oxvig C, Sand O, Kristensen T, Gleich GJ, Sottrup-Jensen L (1993) Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J Biol Chem 268:12243–12246PubMedGoogle Scholar
  86. Oxvig C, Sand O, Kristensen T, Kristensen L, Sottrup-Jensen L (1994b) Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein. Biochim Biophys Acta 1201:415–423PubMedGoogle Scholar
  87. Pan H, Hanada S, Zhao J, Mao L, Ma MZ (2012) Protein secretion is required for pregnancy-associated plasma protein-A to promote lung cancer growth in vivo. PLoS One 7:e48799PubMedCentralPubMedGoogle Scholar
  88. Pollak M (2012) The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer 12:159–169PubMedGoogle Scholar
  89. Popken-Harris P, Checkel J, Loegering D, Madden B, Springett M, Kephart G, Gleich GJ (1998) Regulation and processing of a precursor form of eosinophil granule major basic protein (ProMBP) in differentiating eosinophils. Blood 92:623–631PubMedGoogle Scholar
  90. Qin QP, Christiansen M, Oxvig C, Pettersson K, Sottrup-Jensen L, Koch C, Norgaard-Pedersen B (1997) Double-monoclonal immunofluorometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for Down syndrome. Clin Chem 43:2323–2332PubMedGoogle Scholar
  91. Qin X, Byun D, Lau KH, Baylink DJ, Mohan S (2000) Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease. Arch Biochem Biophys 379:209–216PubMedGoogle Scholar
  92. Qin X, Wergedal JE, Rehage M, Tran K, Newton J, Lam P, Baylink DJ, Mohan S (2006) Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo. Endocrinology 147:5653–5661PubMedCentralPubMedGoogle Scholar
  93. Rehage M, Mohan S, Wergedal JE, Bonafede B, Tran K, Hou D, Phang D, Kumar A, Qin X (2007) Transgenic overexpression of pregnancy-associated plasma protein-A increases the somatic growth and skeletal muscle mass in mice. Endocrinology 148:6176–6185PubMedGoogle Scholar
  94. Resch ZT, Chen BK, Bale LK, Oxvig C, Overgaard MT, Conover CA (2004) Pregnancy-associated plasma protein a gene expression as a target of inflammatory cytokines. Endocrinology 145:1124–1129PubMedGoogle Scholar
  95. Resch ZT, Simari RD, Conover CA (2006) Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury. Endocrinology 147:5634–5640PubMedGoogle Scholar
  96. Ryan AJ, Napoletano S, Fitzpatrick PA, Currid CA, O’Sullivan NC, Harmey JH (2009) Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer. Br J Cancer 101:278–286PubMedCentralPubMedGoogle Scholar
  97. Salim H, Arvanitis A, de Petris L, Kanter L, Haag P, Zovko A, Ozata DM, Lui WO, Lundholm L, Zhivotovsky B, Lewensohn R, Viktorsson K (2013) miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression. Genes Chromosomes Cancer 52:895–911PubMedGoogle Scholar
  98. Samani AA, Yakar S, LeRoith D, Brodt P (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28:20–47PubMedGoogle Scholar
  99. Sinosich MJ (1990) Molecular characterization of pregnancy-associated plasma protein-A by electrophoresis. Electrophoresis 11:70–78PubMedGoogle Scholar
  100. Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OG, Jansson JO, Ohlsson C (1999) Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A 96:7088–7092PubMedCentralPubMedGoogle Scholar
  101. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM (2002) Early-pregnancy origins of low birth weight. Nature 417:916PubMedGoogle Scholar
  102. Soe R, Overgaard MT, Thomsen AR, Laursen LS, Olsen IM, Sottrup-Jensen L, Haaning J, Giudice LC, Conover CA, Oxvig C (2002) Expression of recombinant murine pregnancy-associated plasma protein-A (PAPP-A) and a novel variant (PAPP-Ai) with differential proteolytic activity. Eur J Biochem 269:2247–2256PubMedGoogle Scholar
  103. Suzuki M, Kobayashi H, Tanaka Y, Hirashima Y, Kanayama N, Takei Y, Saga Y, Suzuki M, Itoh H, Terao T (2003) Bikunin target genes in ovarian cancer cells identified by microarray analysis. J Biol Chem 278:14640–14646PubMedGoogle Scholar
  104. Tallant C, Garcia-Castellanos R, Seco J, Baumann U, Gomis-Ruth FX (2006) Molecular analysis of ulilysin, the structural prototype of a new family of metzincin metalloproteases. J Biol Chem 281:17920–17928PubMedGoogle Scholar
  105. Tanaka Y, Kobayashi H, Suzuki M, Hirashima Y, Kanayama N, Terao T (2004) Genetic downregulation of pregnancy-associated plasma protein-A (PAPP-A) by bikunin reduces IGF-I-dependent Akt and ERK1/2 activation and subsequently reduces ovarian cancer cell growth, invasion and metastasis. Int J Cancer 109:336–347PubMedGoogle Scholar
  106. Vallejo AN, Michel JJ, Bale LK, Lemster BH, Borghesi L, Conover CA (2009) Resistance to age-dependent thymic atrophy in long-lived mice that are deficient in pregnancy-associated plasma protein A. Proc Natl Acad Sci U S A 106:11252–11257PubMedCentralPubMedGoogle Scholar
  107. Wagner GF, Dimattia GE (2006) The stanniocalcin family of proteins. J Exp Zool A Comp Exp Biol 305:769–780PubMedGoogle Scholar
  108. Wagner GF, Hampong M, Park CM, Copp DH (1986) Purification, characterization, and bioassay of teleocalcin, a glycoprotein from salmon corpuscles of Stannius. Gen Comp Endocrinol 63:481–491PubMedGoogle Scholar
  109. Wald N, Stone R, Cuckle HS, Grudzinskas JG, Barkai G, Brambati B, Teisner B, Fuhrmann W (1992) First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down’s syndrome. BMJ 305:28PubMedCentralPubMedGoogle Scholar
  110. Welcsh PL, Lee MK, Gonzalez-Hernandez RM, Black DJ, Mahadevappa M, Swisher EM, Warrington JA, King MC (2002) BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci U S A 99:7560–7565PubMedCentralPubMedGoogle Scholar
  111. Weyer K, Boldt HB, Poulsen CB, Kjaer-Sorensen K, Gyrup C, Oxvig C (2007) A substrate specificity-determining unit of three Lin12-Notch repeat modules is formed in trans within the pappalysin-1 dimer and requires a sequence stretch C-terminal to the third module. J Biol Chem 282:10988–10999PubMedGoogle Scholar
  112. Weyer K, Overgaard MT, Laursen LS, Nielsen CG, Schmitz A, Christiansen M, Sottrup-Jensen L, Giudice LC, Oxvig C (2004) Cell surface adhesion of pregnancy-associated plasma protein-A is mediated by four clusters of basic residues located in its third and fourth CCP module. Eur J Biochem 271:1525–1535PubMedGoogle Scholar
  113. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A 96:7324–7329PubMedCentralPubMedGoogle Scholar
  114. Yan X, Baxter RC, Firth SM (2010) Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability. J Clin Endocrinol Metab 95:1412–1420PubMedGoogle Scholar
  115. Yee D (2012) Insulin-like growth factor receptor inhibitors: baby or the bathwater? J Natl Cancer Inst 104:975–981PubMedCentralPubMedGoogle Scholar
  116. Yeung BH, Law AY, Wong CK (2012) Evolution and roles of stanniocalcin. Mol Cell Endocrinol 349:272–280PubMedGoogle Scholar

Copyright information

© The International CCN Society 2015

Authors and Affiliations

  1. 1.Department of Molecular Biology and GeneticsAarhus UniversityAarhus CDenmark

Personalised recommendations